6NOVEMBER - 2020TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comIt's been close to three decades since the completion of the Human Genome Project (HGP), and the genomics field has advanced with extreme rapidity on a technological level since then. Thanks to the advent of next-generation sequencing, the field had completely transformed by the beginning of this decade. Today, the widespread availability of DNA sequencing data has afforded genomics research unprecedented capabilities to provide critical insights regarding chronic diseases and complex traits. As we speak, genomic sequencing is playing a vital role along with cutting-edge technologies, such as artificial intelligence (AI) and big data, in helping the scientists understand and treat SARS-CoV-2, the virus responsible for the current pandemic.Interestingly, genomics is poised to fundamentally shift how healthcare is approached and delivered in the coming years. new DNA technologies are swiftly being developed and will have an increasing impact on the everyday life of people. From giving insights into cancer's origins to enhancing gene therapies to single-cell sequencing platforms, the developments in genomics will play a mounting role in various fields, including clinical genetics, disease gene discovery, drug development, and evolutionary analysis.In this edition of Pharma Tech Outlook, we present to you the story of some of the most promising genomics solution providers that deliver the best outcomes for their clients. This edition also offers a combination of thought leadership articles from subject matter experts and exclusive insights from CIOs and CXOs. We hope this edition will provide you with the right assistance in choosing the best genomics solution provider according to your requirements.Let us know your thoughts!The Future of Genomics is HereCopyright © 2020 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.NOVEMBER - 30 - 2020, Vol 06 - Issue 27 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerChris LynnEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405David ParkerTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >